Moderna Stock Gaps Lower After Earnings

The drugmaker is facing problems in the U.S. and abroad Moderna Inc (NASDAQ:MRNA) stock is freefalling this morning, last seen down 15.2% to trade at $95.48 and pacing for its worst day since November 2021 after the company's second-quarter financial results. The drugmaker reported revenue and losses that beat Wall Street's estimates, but also lowered its full-year sales guidance due to problems stateside and abroad. Specifically, Moderna is facing increased competition for respiratory vaccines in the U.S. ...